Skip to main content
Top
Published in: Journal of Cardiovascular Translational Research 6/2019

01-12-2019 | Carpal Tunnel Syndrome | Original Article

Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome

Authors: Isabel Zegri-Reiriz, F. Javier de Haro-del Moral, Fernando Dominguez, Clara Salas, Pablo de la Cuadra, Aresio Plaza, Isabel Krsnik, Esther Gonzalez-Lopez, Pablo Garcia-Pavia

Published in: Journal of Cardiovascular Translational Research | Issue 6/2019

Login to get access

Abstract

Carpal tunnel syndrome (CTS) is a common finding among patients with cardiac amyloidosis. We sought to determine the prevalence of cardiac amyloidosis in patients who had undergone CTS surgery. From 2005 to 2014, 308 patients ≥ 60 years underwent CTS surgery. Of these, 233 (76%) agreed to participate in the study and 101 (73 ± 8 years; 68% females) showed left ventricular hypertrophy (LVH) ≥ 12 mm and underwent additional studies to diagnose AL and ATTR amyloidosis. Based on complementary studies, three patients were diagnosed with cardiac amyloidosis (two wild-type ATTR and one AL). The three patients showed bilateral CTS with no occupational risk factors. Prevalence of cardiac amyloidosis in the overall cohort was only 1.2% (3/233), but among patients with LVH and bilateral CTS, the prevalence was 5.5% (3/55) and 13.6% (3/22) if cases with an occupational risk factor were excluded. Cardiac amyloidosis should be excluded in the presence of bilateral CTS and particularly if an occupational risk factor is absent.
Literature
1.
go back to reference González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., et al. (2015). Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. European Heart Journal, 36, 2585–2594.CrossRef González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., et al. (2015). Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. European Heart Journal, 36, 2585–2594.CrossRef
2.
go back to reference Maurer, M. S., Elliot, P., Comenzo, R., et al. (2017). Addressing common questions encountered in the diagnosis and Management of Cardiac Amyloidosis. Circulation, 135, 1357–1377.CrossRef Maurer, M. S., Elliot, P., Comenzo, R., et al. (2017). Addressing common questions encountered in the diagnosis and Management of Cardiac Amyloidosis. Circulation, 135, 1357–1377.CrossRef
3.
go back to reference Coelho, T., Maia, L. F., Martins da Silva, A., et al. (2012). Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology, 79, 785–792.CrossRef Coelho, T., Maia, L. F., Martins da Silva, A., et al. (2012). Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology, 79, 785–792.CrossRef
4.
go back to reference Ackermann, E. J., Guo, S., Booten, S., et al. (2012). Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid, 19, 43–44.CrossRef Ackermann, E. J., Guo, S., Booten, S., et al. (2012). Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid, 19, 43–44.CrossRef
5.
go back to reference González-López, E., López-Sainz, Á., & Garcia-Pavia, P. (2017). Diagnosis and treatment of Transthyretin cardiac amyloidosis. Progress and hope. Revista Española de Cardiología, 70, 991–1004.CrossRef González-López, E., López-Sainz, Á., & Garcia-Pavia, P. (2017). Diagnosis and treatment of Transthyretin cardiac amyloidosis. Progress and hope. Revista Española de Cardiología, 70, 991–1004.CrossRef
6.
go back to reference Rapezzi, C., Merlini, G., Quarta, C. C., et al. (2009). Systemic cardiac amyloidosis: disease profiles and clinical courses of the 3 main types. Circulation, 120, 1203–1212.CrossRef Rapezzi, C., Merlini, G., Quarta, C. C., et al. (2009). Systemic cardiac amyloidosis: disease profiles and clinical courses of the 3 main types. Circulation, 120, 1203–1212.CrossRef
7.
go back to reference Nakagawa, M., Sekijima, Y., Yazaki, M., et al. (2016). Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid, 23, 58–63.CrossRef Nakagawa, M., Sekijima, Y., Yazaki, M., et al. (2016). Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid, 23, 58–63.CrossRef
8.
go back to reference Takei, Y., Hattori, T., Gono, T., et al. (2002). Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome. Amyloid, 9, 252–255.CrossRef Takei, Y., Hattori, T., Gono, T., et al. (2002). Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome. Amyloid, 9, 252–255.CrossRef
9.
go back to reference Gillmore, J. D., Maurer, M. S., Falk, R. H., et al. (2016). Non-biopsy diagnosis of cardiac Transthyretin amyloidosis. Circulation, 133, 2404–2412.CrossRef Gillmore, J. D., Maurer, M. S., Falk, R. H., et al. (2016). Non-biopsy diagnosis of cardiac Transthyretin amyloidosis. Circulation, 133, 2404–2412.CrossRef
10.
go back to reference de Haro-del Moral, F. J., Sanchez-Lajusticia, A., Gomez-Bueno, M., Garcia-Pavia, P., Salas-Anton, C., & Segovia-Cubero, J. (2012). Role of cardiac scintigraphy with (9)(9)mTc-DPD in the differentiation of cardiac amyloidosis subtype. Rev Esp Cardiol, 65, 440–446.CrossRef de Haro-del Moral, F. J., Sanchez-Lajusticia, A., Gomez-Bueno, M., Garcia-Pavia, P., Salas-Anton, C., & Segovia-Cubero, J. (2012). Role of cardiac scintigraphy with (9)(9)mTc-DPD in the differentiation of cardiac amyloidosis subtype. Rev Esp Cardiol, 65, 440–446.CrossRef
11.
go back to reference Lousada, I., Comenzo, R. L., Landau, H., et al. (2015). Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Advances in Therapy, 32, 920–928.CrossRef Lousada, I., Comenzo, R. L., Landau, H., et al. (2015). Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Advances in Therapy, 32, 920–928.CrossRef
12.
go back to reference González-López, E., Gagliardi, C., Dominguez, F., et al. (2017). Clinical characteristics of wild-type transthyretin cardiac amyloidosis – disproving myths. European Heart Journal, 38, 1895–1904.CrossRef González-López, E., Gagliardi, C., Dominguez, F., et al. (2017). Clinical characteristics of wild-type transthyretin cardiac amyloidosis – disproving myths. European Heart Journal, 38, 1895–1904.CrossRef
13.
go back to reference Sekijima, Y., Uchiyama, S., Tojo, K., et al. (2011). High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Human Pathology, 42, 1785–1791.CrossRef Sekijima, Y., Uchiyama, S., Tojo, K., et al. (2011). High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Human Pathology, 42, 1785–1791.CrossRef
14.
go back to reference Geller, H. I., Singh, A., Alexander, K. M., et al. (2017). Association between ruptured distal biceps tendon and wild-type Transthyretin cardiac amyloidosis. JAMA, 318, 962–963.CrossRef Geller, H. I., Singh, A., Alexander, K. M., et al. (2017). Association between ruptured distal biceps tendon and wild-type Transthyretin cardiac amyloidosis. JAMA, 318, 962–963.CrossRef
15.
go back to reference Donnelly, J. P., & Hanna, M. (2017). Cardiac amyloidosis: an update on diagnosis and treatment. Cleveland Clinic Journal of Medicine, 84, 12–26.CrossRef Donnelly, J. P., & Hanna, M. (2017). Cardiac amyloidosis: an update on diagnosis and treatment. Cleveland Clinic Journal of Medicine, 84, 12–26.CrossRef
Metadata
Title
Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome
Authors
Isabel Zegri-Reiriz
F. Javier de Haro-del Moral
Fernando Dominguez
Clara Salas
Pablo de la Cuadra
Aresio Plaza
Isabel Krsnik
Esther Gonzalez-Lopez
Pablo Garcia-Pavia
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 6/2019
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-019-09895-0

Other articles of this Issue 6/2019

Journal of Cardiovascular Translational Research 6/2019 Go to the issue